Company Profile
Livzon Pharmaceutical researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People's Republic of China and globally. The company offers leuprorelin acetate microspheres, urofollitropin, and menotropins for injection for the assisted reproduction field.
Its portfolio also includes Ilaprazole enteric-coated tablets, ilaprazole sodium for injection, and bismuth potassium citrate products for the gastrointestinal field, fluvoxamine maleate for the psychiatric and neurological field, and shenqi fuzheng injection and anti-viral granules for the traditional Chinese medicine field.
It also produces APIs and intermediates, such as mevastatin, acarbose, teicoplanin, gentamycin sulfate, phenylalanine, vancomycin hydrochloride, daptomycin, milbemycin oxime, and ceftriaxone sodium diagnostic reagents such as diagnostic kits for IgM antibody to mycoplasma pneumonia.
Its portfolio also includes diagnostic kits for human immunodeficiency virus antibody, and livzon antinuclear antibody test kits, as well as nucleic acid test kits. Its portfolio also includes livzon interferon-gamma release assays test kits, influenza A/B virus antigen detection kits, and treponema pallidum antibody detection kits.
It also provides biochemical drugs, microbiological preparations, biologic products, Chinese drug preparations and pharmaceutical raw materials, stomatitis granules, biochemical and polypeptide APIs, and antibiotic APIs diagnostic equipment. Incorporated in 1985, Livzon Pharmaceutical is headquartered in Zhuhai, China.